Hologram QSAR model for the prediction of human oral bioavailability.
about
Advances in computationally modeling human oral bioavailabilitySystems biological approach of molecular descriptors connectivity: optimal descriptors for oral bioavailability predictionApplying linear and non-linear methods for parallel prediction of volume of distribution and fraction of unbound drugIdentification of Metabotropic Glutamate Receptor Subtype 5 Potentiators Using Virtual High-Throughput Screening.Critical evaluation of human oral bioavailability for pharmaceutical drugs by using various cheminformatics approaches.De novo design: balancing novelty and confined chemical space.Applying machine learning techniques for ADME-Tox prediction: a review.Hologram quantitative structure-activity relationship and comparative molecular interaction field analysis of aminothiazole and thiazolesulfonamide as reversible LSD1 inhibitors.The advancement of multidimensional QSAR for novel drug discovery - where are we headed?A Fragment-Based Approach for the Computational Prediction of the Nonspecific Binding of Drugs to Hepatic Microsomes.Computational strategies to explore antimalarial thiazine alkaloid lead compounds based on an Australian marine sponge Plakortis Lita.A prediction model for oral bioavailability of drugs using physicochemical properties by support vector machine.Fragment-based QSAR strategies in drug design.Synthesis of chiral aliphatic amines through asymmetric hydrogenation.QSAR analysis of thiolactone derivatives using HQSAR, CoMFA and CoMSIA.
P2860
Q27008316-9A294B6F-D18D-44E4-89DB-CB3AB6952730Q28481355-EFDFC5DD-CB6F-480F-8A13-914196E9D0C8Q28534159-7F677060-3305-43EA-AFD9-7E63060CE761Q30481884-98D7A4BC-26C9-45A5-9B81-50BDA22F7FC0Q37639371-3F55C03A-3C8B-499C-B904-73A97600732AQ38029143-B54044EB-113A-4EAF-B52D-14EEFC17F269Q38273839-9C826D84-1C77-47CB-8A84-8426AE05044BQ38979020-D866A5D7-A745-4A72-AE53-B51BE55FF151Q39340690-B56A460B-2CF1-42CC-9DF3-A673C345C25DQ39471808-4D067C5F-A21C-455A-8445-C35B7D9908B7Q39520117-69228828-7D6B-4645-9BED-71AE7C5AC490Q40971280-5270F0A1-C39C-4453-A3C3-2B0D2798F21AQ43539084-BCCE270E-182D-4D54-A9D7-99EAF8B2EDD5Q43728810-C2CE4DBB-0A28-4633-9146-3722BC92F875Q47934612-1FA9739D-02EB-4006-B3B2-C1641B7332A9
P2860
Hologram QSAR model for the prediction of human oral bioavailability.
description
2007 nî lūn-bûn
@nan
2007 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Hologram QSAR model for the prediction of human oral bioavailability.
@ast
Hologram QSAR model for the prediction of human oral bioavailability.
@en
Hologram QSAR model for the prediction of human oral bioavailability.
@nl
type
label
Hologram QSAR model for the prediction of human oral bioavailability.
@ast
Hologram QSAR model for the prediction of human oral bioavailability.
@en
Hologram QSAR model for the prediction of human oral bioavailability.
@nl
prefLabel
Hologram QSAR model for the prediction of human oral bioavailability.
@ast
Hologram QSAR model for the prediction of human oral bioavailability.
@en
Hologram QSAR model for the prediction of human oral bioavailability.
@nl
P921
P1476
Hologram QSAR model for the prediction of human oral bioavailability.
@en
P2093
Adriano D Andricopulo
Tiago L Moda
P304
P356
10.1016/J.BMC.2007.08.060
P407
P577
2007-09-01T00:00:00Z